Mary Anne Rhyne
PER
Rhyne Mary Anne Rhyne
Mary Anne Rhyne, a spokeswoman for GlaxoSmithKline, said the company was considering legal action. Ms.Rhyne would not say whether the target of those actions would be the agency or the generic's maker, Roxane Laboratories. A spokeswoman for GlaxoSmithKline, Mary Anne Rhyne, said the company was considering legal action but she would not say whether the target of those actions would be the agency or the generic's maker, Roxane Laboratories.